EHRA 22: Results From the POWER-FAST III Trial

Published: 06 Apr 2022

  • Views:

    Views Icon 700
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating
Download Transcript

In this late-breaking interview filmed at EHRA 2022, Dr José Merino(Hospital Universitario La Paz, Madrid, Spain) discusses the findings of the POWER-FAST III trial, a study that aimed to compare atrial fibrillation ablation strategies of conventional radiofrequency ablation and high power radiofrequency ablation. Results suggest that PVA was achieved in both cohorts, with no significant differences between the techniques.

Discussion Points:

  1. Aim of this study
  2. Patient population and study design
  3. Main findings
  4. Take-home messages
  5. Further research required

Recorded on-site in Copenhagen, EHRA Conference 2022.

Interviewer: Jonathan McKenna

Editor: Jordan Rance